At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 160 enrolled
Drug / intervention
Preservative Free Morphine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery: A Prospective Double Blind Randomized Control Trial
In Brief
A Phase 4 clinical trial evaluating Preservative Free Morphine and Saline for Postpartum Pain and 2 related conditions. Completed, enrolled 160 participants across 1 site.
Detailed Summary
Patients presenting for normal spontaneous vaginal delivery who have a neuraxial anesthestic will be randomized to receive preservative free morphine or saline placebo after delivery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostpartum Pain, Postpartum Depression, Opioid Consumption
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
First PostedJul 2019
Enrollment StartOct 2019
Primary CompletionAug 2023
TodayJul 2026
First PostedJul 12, 2019
Enrollment StartOct 19, 2019
Primary CompletionAug 31, 2023
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 7.0 years ago
Interventions
Preservative Free Morphinedrug
After delivery of the baby patients will receive via the epidural catheter prior to its removal.
Salinedrug
After delivery of the baby patients will receive via the epidural catheter prior to its removal.